{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:19:24Z","timestamp":1789827564563,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ourofino Sa\u00fade Animal Ltda, Cravinhos, SP, Brazil"},{"name":"Roslin Institute Strategic Programme Control of Infectious Diseases","award":["BBS\/E\/D\/20002173"],"award-info":[{"award-number":["BBS\/E\/D\/20002173"]}]},{"name":"Roslin Institute Strategic Programme Control of Infectious Diseases","award":["BBS\/E\/D\/20002174"],"award-info":[{"award-number":["BBS\/E\/D\/20002174"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.vaccine.2019.09.029","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T16:27:08Z","timestamp":1568651228000},"page":"6688-6695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9642-0904","authenticated-orcid":false,"given":"Tanja","family":"Opriessnig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra M.M.G.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anbu K.","family":"Karuppanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip C.","family":"Gauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Halbur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon R.","family":"Matzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Jin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.09.029_b0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/295064a0","article-title":"A very small porcine virus with circular single-stranded DNA","volume":"295","author":"Tischer","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.09.029_b0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/104063870701900601","article-title":"Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies","volume":"19","author":"Opriessnig","year":"2007","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2019.09.029_b0015","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/tbed.12721","article-title":"Retrospective study of Porcine circovirus type 2 infection reveals a novel genotype PCV2f","volume":"65","author":"Bao","year":"2018","journal-title":"Transb Emerg Dis"},{"key":"10.1016\/j.vaccine.2019.09.029_b0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12917-019-1859-z","article-title":"Genetic analysis of Porcine circovirus type 2 (PCV2) strains between 2002 and 2016 reveals PCV2 mutant predominating in porcine population in Guangxi, China","volume":"15","author":"Yao","year":"2019","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2019.09.029_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208585","article-title":"Porcine circovirus 2 (PCV-2) genotype update and proposal of a new genotyping methodology","volume":"13","author":"Franzo","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.09.029_b0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1017\/S1466252310000162","article-title":"Epidemiology and horizontal transmission of Porcine circovirus type 2 (PCV2)","volume":"11","author":"Patterson","year":"2010","journal-title":"Anim Health Res Rev"},{"key":"10.1016\/j.vaccine.2019.09.029_b0035","first-page":"761","article-title":"Porcine circovirus-2 associated disease in swine in Ontario (2004 to 2005)","volume":"47","author":"Carman","year":"2006","journal-title":"Can Vet J"},{"key":"10.1016\/j.vaccine.2019.09.029_b0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.vetmic.2007.09.016","article-title":"Genomic analysis of PCV2 isolates from Danish archives and a current PMWS case-control study supports a shift in genotypes with time","volume":"128","author":"Dupont","year":"2008","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.vetmic.2015.05.003","article-title":"Genetic characterisation of Porcine circovirus type 2 (PCV2) strains from feral pigs in the Brazilian Pantanal: an opportunity to reconstruct the history of PCV2 evolution","volume":"178","author":"Franzo","year":"2015","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0050","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1099\/vir.0.000100","article-title":"Global molecular genetic analysis of Porcine circovirus type 2 (PCV2) sequences confirms the presence of four main PCV2 genotypes and reveals a rapid increase of PCV2d","volume":"96","author":"Xiao","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.virusres.2016.02.010","article-title":"Diagnostic phylogenetics reveals a new Porcine circovirus 2 cluster","volume":"217","author":"Davies","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2019.09.029_b0060","article-title":"Whole-Genome sequences of novel Porcine circovirus type 2 viruses detected in swine from Mexico and the United States","author":"Harmon","year":"20153","journal-title":"Genome Announc"},{"key":"10.1016\/j.vaccine.2019.09.029_b0065","article-title":"Detection of PCV2e strains in Southeast China","volume":"6","author":"Liu","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.vaccine.2019.09.029_b0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virusres.2011.09.014","article-title":"Concurrent infections are important for expression of Porcine circovirus associated disease","volume":"164","author":"Opriessnig","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2019.09.029_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/v11020185","article-title":"Co-infection of swine with Porcine circovirus type 2 and other swine viruses","volume":"11","author":"Ouyang","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2019.09.029_b0080","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1354\/vp.41-6-624","article-title":"Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and Porcine circovirus type 2","volume":"41","author":"Opriessnig","year":"2004","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.theriogenology.2011.02.014","article-title":"Porcine circovirus type 2 (PCV2) vaccination is effective in reducing disease and PCV2 shedding in semen of boars concurrently infected with PCV2 and Mycoplasma hyopneumoniae","volume":"76","author":"Opriessnig","year":"2011","journal-title":"Theriogenology"},{"key":"10.1016\/j.vaccine.2019.09.029_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/v9050099","article-title":"Porcine circovirus type 2 (PCV2) vaccines in the context of current molecular epidemiology","volume":"9","author":"Karuppannan","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2019.09.029_b0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.prevetmed.2013.02.010","article-title":"Cost of post-weaning multi-systemic wasting syndrome and Porcine circovirus type-2 subclinical infection in England \u2013 an economic disease model","volume":"110","author":"Alarcon","year":"2013","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2019.09.029_b0100","doi-asserted-by":"crossref","first-page":"12469","DOI":"10.1128\/JVI.02345-12","article-title":"Complete genome sequence of a novel Porcine circovirus type 2b variant present in cases of vaccine failures in the United States","volume":"86","author":"Xiao","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0105","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1007\/s00705-014-2164-6","article-title":"Genetic and antigenic characterization of a newly emerging Porcine circovirus type 2b mutant first isolated in cases of vaccine failure in Korea","volume":"159","author":"Seo","year":"2014","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0110","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00163-14","article-title":"Identification of an emergent Porcine circovirus-2 in vaccinated pigs from a Brazilian farm during a postweaning multisystemic wasting syndrome outbreak","volume":"2","author":"Salgado","year":"2014","journal-title":"Genome Announc"},{"key":"10.1016\/j.vaccine.2019.09.029_b0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.vetmic.2015.01.013","article-title":"Detection of a new cluster of Porcine circovirus type 2b strains in domestic pigs in Germany","volume":"176","author":"Eddicks","year":"2015","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vetmic.2016.10.002","article-title":"Ten years of PCV2 vaccines and vaccination: Is eradication a possibility?","volume":"206","author":"Afghah","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0125","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.vaccine.2016.11.085","article-title":"A commercial Porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naive pigs under experimental conditions","volume":"35","author":"Opriessnig","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.029_b0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vetmic.2019.03.002","article-title":"Evaluation of a Porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge","volume":"231","author":"Park","year":"2019","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0135","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1016\/j.vaccine.2016.06.005","article-title":"A commercial PCV2a-based vaccine significantly reduces PCV2b transmission in experimental conditions","volume":"34","author":"Rose","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.029_b0140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.vaccine.2012.11.030","article-title":"A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a\/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection","volume":"31","author":"Opriessnig","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.029_b0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.vaccine.2013.11.010","article-title":"A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain","volume":"32","author":"Opriessnig","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.029_b0150","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.vaccine.2014.02.088","article-title":"Interaction of Porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs","volume":"32","author":"Seo","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.029_b0155","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2460\/ajvr.1984.45.10.1899","article-title":"Characteristics of protective activity of Mycoplasma hyopneumoniae vaccine","volume":"45","author":"Ross","year":"1984","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2019.09.029_b0160","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1099\/vir.0.2008\/001081-0","article-title":"Differences in virulence among Porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection","volume":"89","author":"Opriessnig","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0165","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1354\/vp.40-5-521","article-title":"Effect of vaccination with selective bacterins on conventional pigs infected with type 2 Porcine circovirus","volume":"40","author":"Opriessnig","year":"2003","journal-title":"Vet Path"},{"key":"10.1016\/j.vaccine.2019.09.029_b0170","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1099\/vir.0.000206","article-title":"Assessment of neutralizing and non-neutralizing antibody responses against Porcine circovirus 2 in vaccinated and non-vaccinated farmed pigs","volume":"96","author":"Worsfold","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0175","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/0300985812439724","article-title":"Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A\/H1N1 influenza virus","volume":"49","author":"Gauger","year":"2012","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/030098589603300205","article-title":"Comparison of the antigen distribution of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus","volume":"33","author":"Halbur","year":"1996","journal-title":"Vet Path"},{"key":"10.1016\/j.vaccine.2019.09.029_b0180","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/104063879901100607","article-title":"Development of a polyclonal-antibody-based immunohistochemical method for the detection of type 2 Porcine circovirus in formalin-fixed, paraffin-embedded tissue","volume":"11","author":"Sorden","year":"1999","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2019.09.029_b0195","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.vetmic.2003.10.013","article-title":"The clinical expression and emergence of Porcine circovirus 2","volume":"98","author":"Harding","year":"2004","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0200","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1128\/JCM.38.7.2494-2503.2000","volume":"38","author":"Fenaux","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/01652176.2000.9695049","article-title":"Isolation and characterization of Porcine circovirus type 2 from pigs showing signs of post-weaning multisystemic wasting syndrome in The Netherlands","volume":"22","author":"Wellenberg","year":"2000","journal-title":"Vet Q"},{"key":"10.1016\/j.vaccine.2019.09.029_b0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vetmic.2012.12.019","article-title":"Emergence of a novel mutant PCV2b variant associated with clinical PCVAD in two vaccinated pig farms in the U.S. concurrently infected with PPV2","volume":"163","author":"Opriessnig","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.09.029_b0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.vetmic.2014.08.008","article-title":"Antibody responses of swine following infection with Mycoplasma hyopneumoniae, M. hyorhinis, M. hyosynoviae and M. flocculare","volume":"174","author":"Gomes Neto","year":"2014","journal-title":"Vet Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19312290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19312290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:36:33Z","timestamp":1759401393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19312290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":42,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0264410X19312290"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}